Population
Cultured vascular smooth muscle and endothelial cells
Design
Preclinical
Follow-up
up to 24 h
Authors
Loading...
May control vascular cell cGMP levels; leaves open human translation and therapeutic targeting.
The egression of cyclic GMP from vascular cells is an active, regulated transport process that may significantly contribute to controlling intracellular cyclic GMP levels.
Hamet et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: